Loading…
Elucidata's Polly platform accelerates biomarker discovery by transforming heterogeneous biomedical data into ML-ready formats for analysis. It enables researchers to classify, validate, and benchmark biomarkers using harmonized multi-omics data and public datasets.
AI named Elucidata Polly from December 2025 to February 2026.